Historical record - last NADAC effective date: 8/23/2023
This NDC is on FDA's drug shortage list (posted Feb 22, 2012)
Reported reason: Other
Product Information
LIDOCAINE 2%-EPI 1:100,000 is a generic product labeled by Hospira Inc., priced at $0.1340 per ML under NDC 00409318201. Its NADAC has been published 52 times since Aug 23, 2023.
FDA first approved this application on Jun 21, 1988.
Strength
10; 20 ug/mL; mg/mL
Manufacturer
Hospira Inc.NDC
00409318201
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INFILTRATION; PERINEURAL
Effective Date
8/23/2023
Active Ingredients
EPINEPHRINE; LIDOCAINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA089646FDA Approved
6/21/1988
On Market Since
6/23/2005
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE 2%-EPI 1:100,000 has been published 52 times since Aug 23, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1340 per ML |
|---|---|
| All-time high | $0.1340 (Aug 14, 2024) |
| All-time low | $0.1340 (Aug 23, 2023) |
| Median price | $0.1340 |
| Average price | $0.1340 |
| Largest weekly change | 0.0% (Aug 30, 2023) |
| Weeks tracked | 52 |
| Tracking since | Aug 23, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Aug 14, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the LIDOCAINE HYDROCHLORIDE and EPINEPHRINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LIDOCAINE 2%-EPI 1:100,000?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE 2%-EPI 1:100,000, manufactured by Hospira Inc., is $0.1340 per ML (NDC 00409318201), effective Aug 14, 2024.
How has the price of LIDOCAINE 2%-EPI 1:100,000 changed over time?
Over the history we have for it, the NADAC for LIDOCAINE 2%-EPI 1:100,000 has held within roughly two percent of its current level. It has been tracked across 52 weekly CMS publications since Aug 23, 2023.
What are the highest and lowest recorded NADAC prices for LIDOCAINE 2%-EPI 1:100,000?
Since Aug 23, 2023, the NADAC for LIDOCAINE 2%-EPI 1:100,000 has ranged from a low of $0.1340 (Aug 23, 2023) to a high of $0.1340 (Aug 14, 2024), with a median of $0.1340 per ML.
Are there cheaper alternatives to LIDOCAINE 2%-EPI 1:100,000?
No other NADAC-published product currently shares the active ingredient and strength of LIDOCAINE 2%-EPI 1:100,000 in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LIDOCAINE 2%-EPI 1:100,000?
LIDOCAINE 2%-EPI 1:100,000 (NDC 00409318201) is labeled by Hospira Inc., and CMS classifies it as a generic product.
Is LIDOCAINE 2%-EPI 1:100,000 in shortage?
Yes — NDC 00409318201 is currently listed in FDA's drug shortage database (posted Feb 22, 2012). Reported reason: Other.